Inventor · disambiguated record
Minghan Wang
Also filed as: WANG MINGHAN
12 granted patents·9 pending applications·27 citations·filing 2001–2025
87Inventor score
Files withPHANES THERAPEUTICS INC16AMGEN INC1LU SHU-CHEN1PHANES THERAPEUTIS INC1PHANESTHERAPEUTICS INC1
Top patents by PatentIndex Score
21 records- 0189US11299550B2Anti-CD73 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·9 cites·20 claims
- 0287US11555070B2Anti-claudin 18.2 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jan 17, 2023·3 cites·16 claims
- 0386US12325745B2Anti-DLL3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2024·Granted Jun 10, 2025·0 cites·8 claims
- 0486US12037391B2Anti-DLL3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jul 16, 2024·2 cites·9 claims
- 0586US11390679B2Anti-LAG-3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Jul 19, 2022·4 cites·17 claims
- 0684US11214615B2Anti-TIM-3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Jan 4, 2022·2 cites·18 claims
- 0778US11873335B2Anti-folate receptor 1 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jan 16, 2024·1 cites·13 claims
- 0878US2025257127A1Anti-DLL3 Antibodies and Uses ThereofPHANES THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0975US11306151B2Anti-TIP-1 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Apr 19, 2022·1 cites·11 claims
- 1074US11365242B2Anti-apelin antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Jun 21, 2022·1 cites·36 claims
- 1173US11401329B2Anti-CD47 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Aug 2, 2022·1 cites·17 claims
- 1271US9156911B2Apelin antigen-binding proteins and uses thereofLU SHU-CHEN·Filed 2012·Granted Oct 13, 2015·2 cites·26 claims
- 1369US9493554B2Methods of treating retinal disorders with anti-apelin antibodiesAMGEN INC·Filed 2015·Granted Nov 15, 2016·1 cites·19 claims
- 1453US2023089926A1Antibodies Conjugated with Fatty Acid Molecules and Uses ThereofPHANES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1552US2024124574A1Bispecific Antibodies with Charge Pairs and Uses ThereofPHANES THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1652US2022411497A1Bispecific Antibodies with Alternatively Matched Interchain Cysteines and Uses ThereofPHANES THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1750US2022184127A1Humanized anti-dll3 chimeric antigen receptors and uses thereofPHANES THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1849US2022162301A1Humanized anti-folate receptor 1 chimeric antigen receptors and uses thereofPHANESTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1948US2022184126A1Humanized anti-claudin 18.2 chimeric antigen receptors and uses thereofPHANES THERAPEUTIS INC·Filed 2020·Application pending·0 cites
- 2048US2023220107A1Anti-Tumor Associated Antigen Antibodies and Uses ThereofPHANES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2142US2004048250A1Gene encoding abc-1 paralogs and the polypeptides derived therefromFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Minghan Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →